GlassScriptPhysician profile
Jeffrey John Banks
NPI 1154785343
$2,337.65
in general payments reported to CMS, 2019-2025
15 companies · $1,130 in 2025
The $1,130 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.15 · 2020: $64.82 · 2022: $46.34 · 2023: $192 · 2024: $847 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,169.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $492.85 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Corium, LLC | $409.43 | 2023-2025 | Azstarys |
| Pfizer INC. | $256.42 | 2022-2025 | |
| Lilly USA, LLC | $236.17 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $155.23 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $152.06 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $126.37 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.55 | 2024-2025 | Jardiance |
| Amgen INC. | $109.19 | 2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $100.18 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Verona Pharma, INC. | $89.45 | 2025 | Ohtuvayre |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.66 | 2024-2025 | Trulance, Xifaxan, Relistor |
| Sarepta Therapeutics, INC. | $14.11 | 2024 | Elevidys |
| Phathom Pharmaceuticals, INC. | $13.70 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $13.28 | 2024 | Gardasil 9, M-M-R II, Vaxneuvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Banks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.